Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore
Bicara Therapeutics has officially set the public offering price for its $150 million common stock and pre-funded warrants.

Bicara Therapeutics has officially set the public offering price for its $150 million common stock and pre-funded warrants.

老虎证券老虎证券2026/02/25 04:42
Show original
This financing will support the company in advancing the clinical development of its oncology treatment product pipeline. The market is closely watching the impact of this issuance on the company's future development.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

PoolX: Earn new token airdrops
Lock your assets and earn 10%+ APR
Lock now!